Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mihich

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Medicina|February 24, 2001
New leads in cancer therapeutics: a keynote addressE Mihich
Cancer Detection and Prevention|January 1, 1988
Biological response modifiers in cancer therapeutics: potentialities and limitationsE Mihich
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Modulation of antitumor immune responsesE Mihich
Oncology|January 1, 1980
Biochemical pharmacological determinants of drug action in cancer therapeuticsE Mihich
Cancer Research|April 1, 1975
Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assayH Fuji, E Mihich
Cancer Research|January 13, 2001
Twelfth annual Pezcoller symposium: signaling cross-talks in cancer cellsE Mihich, E Harlow
Cancer Research|March 1, 1980
Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthineD Bogyo, E Mihich
Cancer|July 1, 1977
Multiple basis of combination chemotherapyE Mihich, G B Grindey
International Journal of Immunopharmacology|January 4, 2001
Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumorsE Mihich, M J Ehrke
International Journal of Immunopharmacology|January 1, 1982
Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cellsK H Leung, E Mihich
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Medicina|February 24, 2001
New leads in cancer therapeutics: a keynote addressE Mihich
Cancer Detection and Prevention|January 1, 1988
Biological response modifiers in cancer therapeutics: potentialities and limitationsE Mihich
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Modulation of antitumor immune responsesE Mihich
Oncology|January 1, 1980
Biochemical pharmacological determinants of drug action in cancer therapeuticsE Mihich
Cancer Research|April 1, 1975
Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assayH Fuji, E Mihich
Cancer Research|January 13, 2001
Twelfth annual Pezcoller symposium: signaling cross-talks in cancer cellsE Mihich, E Harlow
Cancer Research|March 1, 1980
Reversal of the in vitro methotrexate suppression of cell-mediated immune response by folinic acid and thymidine plus hypoxanthineD Bogyo, E Mihich
Cancer|July 1, 1977
Multiple basis of combination chemotherapyE Mihich, G B Grindey
International Journal of Immunopharmacology|January 4, 2001
Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumorsE Mihich, M J Ehrke
International Journal of Immunopharmacology|January 1, 1982
Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cellsK H Leung, E Mihich
Pageof 8